RSNA15: Study Shows Link Between Early-Stage Brain and Heart Disease
"We know that myocardial infarction, heart failure and atrial fibrillation are associated with an increased risk of stroke and dementia," says Hazel Zonneveld, MD, MSc, from the Department of Epidemiology and Radiology at Erasmus University Medical Center in Rotterdam. "Our study investigates whether the heart-brain link is present at an earlier stage of disease."
Dr. Zonneveld and colleagues analysed data from 2,432 participants in the Rotterdam Study (57.4 percent women, mean age 56.6 years), a prospective, population-based study designed to investigate chronic diseases in Rotterdam's ageing population. Participants with overt heart disease, dementia and brain infarcts (strokes) were excluded from the analysis.
Participants underwent brain MRI, which included the use of an advanced technique called diffusion tensor imaging (DTI), and blood testing to measure levels of N-terminal pro b-type natriuretic peptide (NT-proBNP) — a marker of heart disease.
"NT-proBNP is released into the bloodstream in response to myocardial wall stress," Dr. Zonneveld explained. "Studies have demonstrated that NT-proBNP provides information on cardiac dysfunction even in the absence of overt heart disease."
Dr. Zonneveld's team evaluated the brain MRI results for markers of early brain disease, including a loss of brain volume, microstructural changes and white matter lesions, which indicate areas of cells that have been damaged by injury or disease.
The results of DTI showed that participants with higher NT-proBNP levels had worse microstructural organization within the white matter. Further analysis revealed that higher NT-proBNP levels were also associated with smaller total brain volume and larger white matter lesion volume. The brain volume loss was mainly in the grey matter, said Dr. Zonneveld.
The study is the first to demonstrate an association between NT-proBNP and the microstructure of the brain, she added.
Editorial Project Director, HealthManagement.org
Source and image credit: RSNA
Published on : Thu, 3 Dec 2015
It's the key to 3T. A system that offers unprecedented access to 3 Tesla magnetic resonance imaging? The answer is MAGNETOM Spectra 1 . It’s the key to a new scope of image and healthcare quality for patients. It’s the key to a new level of usability...
Providing access to mammography for early breast cancer detection can be a challenge, especially when budgets are limited. An analog system that is easy to use and provides images at the right dose is a cost-effective way...
Built specifically around the way you work, the ACUSON NX3™ series ultrasound systems are simple and uncomplicated, yet powerful. When form meets function, the result is an intuitive and smart ultrasound system that will help promote your highest levels...
Created with clinical reliability, process efficiency, and future sustainability in mind, the ACUSON NX2™ ultrasound system is a smart-inspired solution, providing premium imaging performance across clinical applications. ACUSON NX2 Elite is the new...
Newly redesigned Precision Flow Packettes™ allow pinpoint application to a transducer head or skin surface while eliminating the potential for gel cross-contamination. Available for Aquasonic® 100 and hypoallergenic Aquasonic CLEAR®. FEATURES...